NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLL-r B-ALL by regulating NR3C1 expression Blood
Engineering cellular redox homeostasis to optimize ethanol production in xylose-fermenting Saccharomyces cerevisiae strains Microbiol Res
Targeting RNA modifications in leukaemia: Epitranscriptomic drugs are the new kids on the block BRIT J HAEMATOL
Severe ischemia and reperfusion injury induces epigenetic inactivation of LHX1 in kidney progenitor cells after kidney transplantation Am J Transplant
Lung cancer survival trends and prognostic factors: A 26-year population-based study in Girona Province, Spain Lung Cancer
Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia Cell Rep
Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants NPJ Genom Med
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial Lancet Haematol
AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification Blood Adv
Applying Molecular Modeling to the Design of Innovative, Non-Symmetrical CXCR4 Inhibitors with Potent Anticancer Activity Int J Mol Sci